FFO
DGX icon

Fortitude Family Office’s Quest Diagnostics DGX Stock Holding History

Fortitude Family Office’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2K Sell
81
-4
-5% -$785 ﹤0.01% 579
2026
Q1 		$16.7K Buy
85
+38
+81% +$7.38K ﹤0.01% 478
2025
Q4 		$8.16K Sell
47
-2
-4% -$364 ﹤0.01% 652
2025
Q3 		$9.34K Buy
49
+3
+7% +$532 ﹤0.01% 599
2025
Q2 		$8.26K Buy
46
+16
+53% +$2.78K ﹤0.01% 622
2025
Q1 		$5.08K Hold
30
– – ﹤0.01% 724
2024
Q4 		$4.53K Hold
30
– – ﹤0.01% 873
2024
Q3 		$4.66K Hold
30
– – ﹤0.01% 815
2024
Q2 		$4.11K Hold
30
– – ﹤0.01% 663
2024
Q1 		$3.99K Hold
30
– – ﹤0.01% 689
2023
Q4 		$4.14K Buy
+30
New +$3.94K ﹤0.01% 753

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Fortitude Family Office's DGX Position: Q2 2026 in Review

Fortitude Family Office reduced its Quest Diagnostics (DGX) stake by 4.7% in Q2 2026, selling an estimated $785 and leaving 81 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Fortitude Family Office first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Fortitude Family Office held 81 shares of Quest Diagnostics worth $17.2K as of Q2 2026.
  • Fortitude Family Office sold 4 Quest Diagnostics shares in Q2 2026, an estimated $785.
  • Quest Diagnostics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #579 holding.
  • Fortitude Family Office first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.